Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Iovance Biotherapeutics (IOVA) Inventory Average: 2023-2025

Historic Inventory Average for Iovance Biotherapeutics (IOVA) over the last 1 years, with Sep 2025 value amounting to $50.8 million.

  • Iovance Biotherapeutics' Inventory Average was N/A to $50.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $50.8 million, marking a year-over-year change of. This contributed to the annual value of $30.9 million for FY2024, which is N/A change from last year.
  • Latest data reveals that Iovance Biotherapeutics reported Inventory Average of $50.8 million as of Q3 2025, which was down 11.99% from $57.7 million recorded in Q2 2025.
  • Iovance Biotherapeutics' 5-year Inventory Average high stood at $58.5 million for Q1 2025, and its period low was $9.5 million during Q3 2023.
  • In the last 3 years, Iovance Biotherapeutics' Inventory Average had a median value of $32.4 million in 2024 and averaged $33.4 million.
  • Data for Iovance Biotherapeutics' Inventory Average shows a peak YoY surged of 318.25% (in 2025) over the last 5 years.
  • Over the past 3 years, Iovance Biotherapeutics' Inventory Average (Quarterly) stood at $9.8 million in 2023, then reached $14.0 million in 2024, then surged by 318.25% to $50.8 million in 2025.
  • Its Inventory Average stands at $50.8 million for Q3 2025, versus $57.7 million for Q2 2025 and $58.5 million for Q1 2025.